Our study identified 4 genes that potentially correlated with global transcriptomic changes and clinical improvements, including 2 lncRNAs (AC093843.1 and ENSG00000287527) and 2 genes previously associated with DM1 (CDKN1A and DCLK1). This evidence concerns the gene DCLK1 and myotonic dystrophy type 1.